Page last updated: 2024-11-01

norfloxacin and Lung Neoplasms

norfloxacin has been researched along with Lung Neoplasms in 2 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research Excerpts

ExcerptRelevanceReference
"The efficacy of the prophylactic administration of sulfamethoxazole/trimethoprim (ST) plus norfloxacin (NFLX) versus ST alone to prevent the development of bacterial infection during chemotherapy-induced leukopenia was compared in patients with lung cancer."5.08A randomized controlled trial of sulfamethoxazole/trimethoprim plus norfloxacin versus sulfamethoxazole/trimethoprim alone for the prophylaxis of bacteria infection during chemotherapy for lung cancer. ( Kunikane, H; Kunitoh, H; Nagatomo, A; Okamoto, H; Watanabe, K, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bykowska, A1
Komarnicka, UK1
Jeżowska-Bojczuk, M1
Kyzioł, A1
Nagatomo, A1
Watanabe, K1
Kunikane, H1
Okamoto, H1
Kunitoh, H1

Trials

1 trial available for norfloxacin and Lung Neoplasms

ArticleYear
A randomized controlled trial of sulfamethoxazole/trimethoprim plus norfloxacin versus sulfamethoxazole/trimethoprim alone for the prophylaxis of bacteria infection during chemotherapy for lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1998, Volume: 19, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Combin

1998

Other Studies

1 other study available for norfloxacin and Lung Neoplasms

ArticleYear
Cu
    Journal of inorganic biochemistry, 2018, Volume: 181

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Apopt

2018